Sara Lopez-Tarruella

ASSOCIATE PROFESSOR

Universidad Complutense de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sara Lopez-Tarruella is an Associate Professor at Universidad Complutense de Madrid, Spain. Her research primarily focuses on breast cancer, with recent work examining predictive indicators and treatment outcomes in adjuvant chemotherapy, particularly in triple-negative and HR+/HER2− breast cancer subtypes. She has published several articles analyzing prognostic factors and real-world applications of therapeutic strategies in breast cancer management.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (13)

Mariano Ponz-Sarvise

Universidad de Navarra

SPAIN

View details

Álvaro Rodríguez-Lescure

Head

University Hospital Erlangen

SPAIN

View details

Mónica Castellanos Montealegre

Profesora asociada

Universidad de Castilla-La Mancha - Campus de Albacete

SPAIN

View details

Salvador Martín Algarra

Universidad de Navarra

SPAIN

View details

Montserrat Muñoz Mateu

Professora associada

University of Barcelona

SPAIN

View details

Coralia Bueno Muiño

SPAIN

View details

Aranzazu Fernandez-Martinez

University of North Carolina, Lineberger Comprehensive Cancer Center

UNITED STATES

View details

Gaia Griguolo

University of Padua

ITALY

View details

Rachel Yoder

University of Kansas Medical Center

UNITED STATES

View details

María Virginia García Coll

Profesor Asociado

University of Castilla-La Mancha

SPAIN

View details

Shane Stecklein

University of Kansas Cancer Center

UNITED STATES

View details

Juan Romo

Universidad Carlos III de Madrid

SPAIN

View details

Miguel Martin

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sara Lopez-Tarruella

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials

Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies

A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer

TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study

Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain

Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort

Impact of the COVID-19 Lockdown on Physical Activity Levels and Health Parameters in Young Adults with Cancer

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.

Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry

Laser transfer for circulating tumor cell isolation in liquid biopsy.

The importance of physical exercise in cardiovascular fitness in breast cancer survivors. A cross-sectional study: women in Motion 2.0

How we treat HR-positive, HER2-negative early breast cancer

HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Technical Challenges for CTC Implementation in Breast Cancer

Iterative Variable Selection for High-Dimensional Data: Prediction of Pathological Response in Triple-Negative Breast Cancer

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain.

Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations

Collaborators (13)

Mariano Ponz-Sarvise

Álvaro Rodríguez-Lescure

Mónica Castellanos Montealegre

Salvador Martín Algarra

Montserrat Muñoz Mateu

Coralia Bueno Muiño

Aranzazu Fernandez-Martinez

Gaia Griguolo

Rachel Yoder

María Virginia García Coll

Shane Stecklein

Juan Romo

Miguel Martin

Make your next move.